Immunofluorescence assays revealed that KAT6A formed more biomolecular condensates in PARPi‐resistant ovarian cancer than in parental cells (Figure 2A,B; Video S1, Supporting Information). This evidence concerns the gene KAT6A and ovarian carcinoma.